Regulatory and evidence-based considerations for abuse-deterrent opioids

Am J Health Syst Pharm. 2019 Jan 16;76(2):114-118. doi: 10.1093/ajhp/zxy013.
No abstract available

MeSH terms

  • Abuse-Deterrent Formulations*
  • Analgesics, Opioid / administration & dosage*
  • Analgesics, Opioid / adverse effects
  • Drug and Narcotic Control*
  • Evidence-Based Medicine
  • Humans
  • Opioid-Related Disorders / epidemiology
  • Opioid-Related Disorders / prevention & control*
  • United States

Substances

  • Abuse-Deterrent Formulations
  • Analgesics, Opioid